Fyn-Head Tablet
By Fyn-Head
Rx
4 Tablet in a Strip

Composition
Sumatriptan(85mg) + Naproxen(500mg)

Manufacturer - Gonan Pharma
22/351, MHB Colony No. 4, Raoli Camp, Sion (East), Mumbai - 400022

Expires on or after
August, 2025

liver
When taking Fyn-Head Tablet, it is important to be cautious if you have liver disease. Patients with liver conditions may require a dose adjustment when using this medication. It is advisable to seek guidance from your doctor before starting or continuing the use of Fyn-Head Tablet to ensure proper management and safety.

kidney
Fyn-Head Tablet needs caution in kidney disease patients. It may require dose adjustment. Consult your doctor for guidance.

alcohol
It is not safe to drink alcohol while taking Fyn-Head Tablet.

driving
Refrain from driving if you experience dizziness, depression, drowsiness, fatigue, or sleep disturbances while using Fyn-Head Tablet. These side effects may impair your ability to drive safely due to potential vision changes.

pregnancy
Fyn-Head Tablet is considered unsafe during pregnancy based on limited human studies. Animal studies suggest it may harm the developing baby. Your doctor will assess the benefits and risks before prescribing. Please consult your doctor.

breastfeeding
Fyn-Head Tablet is considered safe for breastfeeding moms. Studies show it has minimal transfer into breastmilk and is unlikely to harm the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | - |
Action Class | - |
₹189
Inclusive of all taxes
Content verified by

Dr. Archana Prabhakar
MBBS, M.Med (Family Medicine)
Last update on 01-Oct-2024